Fresh Tracks Therapeutics (FRTX) Revenue & Revenue Breakdown
Fresh Tracks Therapeutics Revenue Highlights
Latest Revenue (Y)
$8.01M
Main Segment (Y)
Consulting Services
Fresh Tracks Therapeutics Revenue by Period
Fresh Tracks Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $8.01M | 15.31% |
| 2022-12-31 | $6.94M | 1618.56% |
| 2021-12-31 | $404.00K | -77.83% |
| 2020-12-31 | $1.82M | -76.99% |
| 2019-12-31 | $7.92M | 388.10% |
| 2018-12-31 | $1.62M | -88.26% |
| 2017-12-31 | $13.82M | -4.90% |
| 2016-12-31 | $14.53M | -30.64% |
| 2015-12-31 | $20.95M | 37.67% |
| 2014-12-31 | $15.22M | 97.16% |
| 2013-12-31 | $7.72M | -55.94% |
| 2012-12-31 | $17.52M | -41.64% |
| 2011-12-31 | $30.02M | 244.60% |
| 2010-12-31 | $8.71M | -31.33% |
| 2009-12-31 | $12.69M | 59.45% |
| 2008-12-31 | $7.96M | 44.34% |
| 2007-12-31 | $5.51M | -62.61% |
| 2006-12-31 | $14.74M | 22.80% |
| 2005-12-31 | $12.00M | -17.48% |
| 2004-12-31 | $14.54M | 80.05% |
| 2003-12-31 | $8.08M | 15.29% |
| 2002-12-31 | $7.01M | -38.35% |
| 2001-12-31 | $11.37M | 49.16% |
| 2000-12-31 | $7.62M | -28.78% |
| 1999-12-31 | $10.70M | 81.36% |
| 1998-12-31 | $5.90M | -24.36% |
| 1997-12-31 | $7.80M | 16.42% |
| 1996-12-31 | $6.70M | 6.35% |
| 1995-12-31 | $6.30M | 14.55% |
| 1994-12-31 | $5.50M | -8.33% |
| 1993-12-31 | $6.00M | - |
Fresh Tracks Therapeutics generated $8.01M in revenue during NA 2023, up 15.31% compared to the previous quarter, and up 493.59% compared to the same period a year ago.
Fresh Tracks Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2023-09-30 | $7.94M | 14888.68% |
| 2023-06-30 | $53.00K | 488.89% |
| 2023-03-31 | $9.00K | -99.56% |
| 2022-12-31 | $2.05M | 321.81% |
| 2022-09-30 | $486.00K | -88.74% |
| 2022-06-30 | $4.32M | 4590.22% |
| 2022-03-31 | $92.00K | -11.54% |
| 2021-12-31 | $104.00K | -21.21% |
| 2021-09-30 | $132.00K | -12.58% |
| 2021-06-30 | $151.00K | 788.24% |
| 2021-03-31 | $17.00K | -37.04% |
| 2020-12-31 | $27.00K | -80.99% |
| 2020-09-30 | $142.00K | -76.61% |
| 2020-06-30 | $607.00K | -41.97% |
| 2020-03-31 | $1.05M | 56.35% |
| 2019-12-31 | $669.00K | -43.45% |
| 2019-09-30 | $1.18M | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | -100.00% |
| 2018-12-31 | $124.00K | 163.83% |
| 2018-09-30 | $47.00K | -93.61% |
| 2018-06-30 | $735.00K | 2.65% |
| 2018-03-31 | $716.00K | -81.89% |
| 2017-12-31 | $3.95M | 22.01% |
| 2017-09-30 | $3.24M | -5.29% |
| 2017-06-30 | $3.42M | 6.74% |
| 2017-03-31 | $3.21M | 1.33% |
| 2016-12-31 | $3.16M | 19.72% |
| 2016-09-30 | $2.64M | -35.90% |
| 2016-06-30 | $4.12M | -10.47% |
| 2016-03-31 | $4.60M | -32.42% |
| 2015-12-31 | $6.81M | 35.80% |
| 2015-09-30 | $5.02M | 20.14% |
| 2015-06-30 | $4.18M | -15.53% |
| 2015-03-31 | $4.94M | 2.51% |
| 2014-12-31 | $4.82M | 40.12% |
| 2014-09-30 | $3.44M | -23.60% |
| 2014-06-30 | $4.50M | 84.10% |
| 2014-03-31 | $2.45M | -22.19% |
| 2013-12-31 | $3.15M | 103.82% |
| 2013-09-30 | $1.54M | 5.98% |
| 2013-06-30 | $1.46M | -7.50% |
| 2013-03-31 | $1.57M | -32.13% |
| 2012-12-31 | $2.32M | 6.62% |
| 2012-09-30 | $2.17M | 38.98% |
| 2012-06-30 | $1.56M | -86.34% |
| 2012-03-31 | $11.46M | 493.17% |
| 2011-12-31 | $1.93M | -92.74% |
| 2011-09-30 | $26.62M | 3154.16% |
| 2011-06-30 | $818.00K | 26.04% |
| 2011-03-31 | $649.00K | -77.74% |
| 2010-12-31 | $2.92M | 29.20% |
| 2010-09-30 | $2.26M | 8.77% |
| 2010-06-30 | $2.08M | 41.83% |
| 2010-03-31 | $1.46M | -42.74% |
| 2009-12-31 | $2.56M | -34.54% |
| 2009-09-30 | $3.90M | -1.89% |
| 2009-06-30 | $3.98M | 76.80% |
| 2009-03-31 | $2.25M | -14.29% |
| 2008-12-31 | $2.63M | 211.02% |
| 2008-09-30 | $844.00K | -66.86% |
| 2008-06-30 | $2.55M | - |
Fresh Tracks Therapeutics generated - in revenue during Q4 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Fresh Tracks Therapeutics Revenue Breakdown
Fresh Tracks Therapeutics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 |
|---|---|
| Consulting Services | $794.00K |
Fresh Tracks Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 22: Consulting Services (100.00%).
Quarterly Revenue by Product
| Product/Service | Sep 23 | Jun 23 |
|---|---|---|
| Consulting Services | - | - |
| Royalty | - | - |
| Product and Service, Other | - | $53.00K |
Fresh Tracks Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| FRTX | Fresh Tracks Therapeutics | $8.01M | - |
| ASMB | Assembly Biosciences | $7.16M | $5.79M |
| SNTI | Senti Biosciences | $2.56M | - |
| SABS | SAB Biotherapeutics | $2.24M | $263.14K |
| BLCM | Bellicum Pharmaceuticals | $1.50M | $1.00M |
| UNCY | Unicycive Therapeutics | $675.00K | - |
| VRAX | Virax Biolabs Group | $8.56K | $76.50K |
| PXMD | PaxMedica | - | - |
| CING | Cingulate | - | - |
| NXTC | NextCure | - | - |
| TIL | Instil Bio | - | - |
| REVB | Revelation Biosciences | - | - |
| HILS | Tharimmune | - | - |
| PCSA | Processa Pharmaceuticals | - | - |
| ACHL | Achilles Therapeutics | - | - |
| THRD | Third Harmonic Bio | - | - |
| NUVB | Nuvation Bio | - | $1.44M |
| QNRX | Quoin Pharmaceuticals | - | - |
| KPRX | Kiora Pharmaceuticals | - | $20.00K |
| CDIO | Cardio Diagnostics | - | $7.87K |
| BWV | Onconetix | - | - |
FRTX Revenue FAQ
What is Fresh Tracks Therapeutics’s yearly revenue?
Fresh Tracks Therapeutics's yearly revenue for 2023 was $8.01M, representing an increase of 15.31% compared to 2022. The company's yearly revenue for 2022 was $6.94M, representing an increase of 1618.56% compared to 2021. FRTX's yearly revenue for 2021 was $404K, representing a decrease of -77.83% compared to 2020.
What is Fresh Tracks Therapeutics’s quarterly revenue?
Fresh Tracks Therapeutics's quarterly revenue for Q4 2023 was $0, a -100.00% decrease from the previous quarter (Q3 2023), and a -100.00% decrease year-over-year (Q4 2022). The company's quarterly revenue for Q3 2023 was $7.94M, a 14888.68% increase from the previous quarter (Q2 2023), and a 1534.57% increase year-over-year (Q3 2022). FRTX's quarterly revenue for Q2 2023 was $53K, a 488.89% increase from the previous quarter (Q1 2023), and a -98.77% decrease year-over-year (Q2 2022).
What is Fresh Tracks Therapeutics’s revenue growth rate?
Fresh Tracks Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 1881.68%, and for the last 5 years (2019-2023) was 1.12%.
What are Fresh Tracks Therapeutics’s revenue streams?
Fresh Tracks Therapeutics's revenue streams in c 22 are Consulting Services
What is Fresh Tracks Therapeutics’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Fresh Tracks Therapeutics was Consulting Services. This segment made a revenue of $794K, representing 100.00% of the company's total revenue.